The Jenner Institute director, Prof Adrian Hill, said the malaria vaccine would be tested on 4,800 children in Africa next year after early trials yielded promising results.
[...]
More than 400,000 people a year die of the disease, and in Africa a child under five dies every two minutes.
[...]
The vaccine could be in use by 2024 if the final human trials are successful, he said. It is regarded as a potentially huge breakthrough, given that no vaccine is fully licensed for malaria despite a century of research. GSK is the only pharmaceutical company to have got close, but its product had only 30% efficacy.
The institute’s coronavirus vaccine is also intended to be cheap and available at scale in developing countries. Trials of the jab will start in Burkina Faso, Kenya, Tanzania and Mali next year. Early phase 2 trials look good so far, and Oxford has joined with the Serum Institute in India to produce doses.
From the article:
[...]
[...]